Client’s Testimonial:
“Thank you very much for your help.”
On May 17th, 2018, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Research Associate in the Field of Medicinal Chemistry (Approval Notice).
General Field: Medicinal Chemistry
Position at the Time of Case Filing: Postdoctoral Research Associate
Country of Origin: China
State of Residence at the Time of Filing: Illinois
Approval Notice Date: May 17th, 2018
Processing Time: 10 Days (Premium Processing Requested)
Case Summary:
The field of medicinal chemistry has seen much progress since our client—a postdoctoral research associate—chose to dedicate his research career to it. When he approached us to help him get one step closer to his green card, we advised him to file two I-140 petitions to increase his chances of I-140 approval. However, because our client filed his EB-1A (Alien of Extraordinary Ability) before his EB-2 NIW (and using Premium Processing), he received notification of EB1A case approval in a mere 10 days. As a Chinese national, our client can undoubtedly move forward in the green card process a lot quicker with an approved EB1A than an approved NIW.
What did the customized EB1A petition contain?
With a success rate of over 10,000 approved I-140 cases, our firm is well-versed in the ins and outs of USCIS adjudication trends. We worked diligently to put together a comprehensive EB1A petition dossier that highlighted our client’s unique skillsets, research field, and background as a prominent medicinal chemist. Amongst other things, we listed the 110 times his half a dozen publications were cited. We also shed light on the 15 times he had assessed the work of his peers for an array of well-known scientific journals.
Gathering supporting evidence:
We knew that if we wanted to attain EB1A approval, we needed external support. Therefore, we urged our client to reach out to several influential members of the medicinal chemistry research community and ask for recommendation letters. Not long after we had helped our client narrow down a list of potential recommenders, he returned with six signed letters, all of which supported our argument that he should be allowed to continue his research in the United States. These letters also provided subjective evidence regarding our client’s respected status as an outstanding researcher. This is a quote extracted from one of these letters: “[Client] is a researcher with levels of expertise and skill that few others in his field match. He is conducting research in an area of great national importance, and he has shown himself to be a valuable asset to the United States.”
We congratulate our client for securing a highly sought-after EB1A approval, and we thank him for trusting us to help him move significantly closer to US permanent residency. We also wish him the best as he continues to carry out specialized research on cancer drug development to benefit the United States.
https://www.yelp.com/biz/north-america-immigration-law-group-ann-arbor